 DUBLIN , June 24, 2021 PRNewswire -- Endo International plc NASDAQ:ENDP announced today that data from studies of Endo Aesthetics Qwo collagenase clostridium histolyticum-aaes, which received FDA approval in July 2020 for the treatment of moderate to severe cellulite in the buttocks of adult women, will be presented during Cosmetic Bootcamp Summer Event. This data will be highlighted in three e-posters that will be available during the virtual and in-person meeting taking place in Aspen, CO, June 2427, 2021. 